Trials / Terminated
TerminatedNCT00797550
Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Vericel Corporation · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis is that Aastrom TRC autologous bone marrow tissue "grafts" can be safely used to promote bone healing as part of a single level posterolateral spine fusion surgical procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Bone Repair Cells (BRCs) | BRCs will be administered during spine fusion surgery |
| PROCEDURE | Autologous bone graft |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2006-08-01
- Completion
- 2008-10-01
- First posted
- 2008-11-25
- Last updated
- 2021-05-11
Source: ClinicalTrials.gov record NCT00797550. Inclusion in this directory is not an endorsement.